- Home
- CRNX vs ESNT Comparison
CRNX vs ESNT Comparison
Compare CRNX & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- ESNT
- Stock Information
- Founded
- CRNX 2008
- ESNT 2008
- Country
- CRNX United States
- ESNT Bermuda
- Employees
- CRNX N/A
- ESNT N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- ESNT Property-Casualty Insurers
- Sector
- CRNX Health Care
- ESNT Finance
- Exchange
- CRNX Nasdaq
- ESNT Nasdaq
- Market Cap
- CRNX 2.8B
- ESNT N/A
- IPO Year
- CRNX 2018
- ESNT 2013
- Fundamental
- Price
- CRNX $41.56
- ESNT $59.50
- Analyst Decision
- CRNX Buy
- ESNT Buy
- Analyst Count
- CRNX 12
- ESNT 6
- Target Price
- CRNX $74.45
- ESNT $65.67
- AVG Volume (30 Days)
- CRNX 2.1M
- ESNT 681.6K
- Earning Date
- CRNX 11-06-2025
- ESNT 11-07-2025
- Dividend Yield
- CRNX N/A
- ESNT 2.08%
- EPS Growth
- CRNX N/A
- ESNT N/A
- EPS
- CRNX N/A
- ESNT 6.85
- Revenue
- CRNX $1,392,000.00
- ESNT $1,268,306,000.00
- Revenue This Year
- CRNX $428.87
- ESNT $4.27
- Revenue Next Year
- CRNX $958.11
- ESNT $1.47
- P/E Ratio
- CRNX N/A
- ESNT $8.68
- Revenue Growth
- CRNX 0.51
- ESNT 5.28
- 52 Week Low
- CRNX $24.10
- ESNT $51.61
- 52 Week High
- CRNX $62.53
- ESNT $65.90
- Technical
- Relative Strength Index (RSI)
- CRNX 54.07
- ESNT 40.32
- Support Level
- CRNX $43.72
- ESNT $58.46
- Resistance Level
- CRNX $45.95
- ESNT $61.02
- Average True Range (ATR)
- CRNX 1.78
- ESNT 1.00
- MACD
- CRNX -0.37
- ESNT -0.39
- Stochastic Oscillator
- CRNX 19.30
- ESNT 15.48
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.